Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients.
Ontology highlight
ABSTRACT: Leukotrienes are important pro-inflammatory lipid mediators derived from the arachidonic acid metabolism. In particular, cysteinyl leukotrienes, namely LTC4, LTD4, and LTE4 are involved in many of the principal features of asthma, while more recently they have also been implicated in cardiovascular diseases. COVID-19 is characterized by an overwhelming state of inflammation, sometimes resulting in an acute respiratory distress syndrome. Furthermore, severe COVID-19 patients present an endothelial cell damage characterized by a hyperinflammatory/procoagulant state and a widespread thrombotic disease. Leukotriene receptor antagonists, such as montelukast, have long been proven to have an efficacy in asthma, while more recently they have been suggested to have
SUBMITTER: Camera M
PROVIDER: S-EPMC8863130 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA